منابع مشابه
Gemcitabine-induced pulmonary toxicity.
BACKGROUND Gemcitabine is the only approved cytotoxic agent for the treatment of pancreatic cancer by the Food and Drug Administration. In addition, gemcitabine is also commonly used for the management of breast, ovarian, and non-small cell lung cancer. Myelosuppression is the most common toxicity of gemcitabine therapy. Pulmonary toxicities due to gemcitabine have, however, been reported. Dysp...
متن کاملAmiodarone-induced pulmonary toxicity
Amiodarone-induced pulmonary toxicity is a critical and potentially fatal side effect of amiodarone. Our study was designed to reveal its clinical features, including KL-6, as an interstitial marker. The medical records of eight patients (five men and three women) with amiodarone-induced pulmonary toxicity, who had been referred to our hospital, were examined. The mean age at the initiation of ...
متن کاملNitrofurantoin‐induced acute pulmonary toxicity
We report a case of a female admitted to the emergency department with fever and severe type I acute respiratory failure. After detailed examination, all other potential causes were excluded and the patient was diagnosed with nitrofurantoin-induced acute pulmonary toxicity.
متن کاملPulmonary toxicity induced by chemical agents.
place special stress on the lung. pleural space can lead to severe transplantation is associated with the of right-sided pleural effusions and right atelectasis, presumably due to subdissection. Most transplantation patients volumes of intravenous fluids and have some underlying disease which can directly or indirectly. The ability of BAL lung is helpful in assessment of the of pulmonary compli...
متن کاملGemcitabine Induced Pulmonary Toxicity with Late Onset
Gemcitabine is a nucleoside analog that has been increasingly used in the chemotherapy of solide tumors, including breast, pancreas ovary and non small cell lung cancer. It is generally well tolerated and has few side effects. Gemcitabine induced pulmonary complications range from mild dyspnea to death from ARDS. A 57yearold man was treated with six cycles of gemcitabine because of pancreatic c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Oncology
سال: 2019
ISSN: 1718-7729
DOI: 10.3747/co.26.5399